Medication info
Losartan 50 mg (Losartan Potassium)

Losartan 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
CTC Bio, Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201507875 · Approved 2015.11.25 · Insurance code 669501660

Summary

Main use
Treatment of kidney disease in patients with hypertension and type 2 diabetes mellitus accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken without regard to meals, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day or, if necessary, increased to a maximum of 100 mg once daily. 3) If blood pressure is not controlled with this drug alone, it may be coadministered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose of this drug is 50 mg once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be coadministered with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this drug once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. 3) Patients with reduced effective intravascular volume An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily and may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily and may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children younger than 6 years: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
CTC Bio, Co., Ltd.

Efficacy & effects

Treatment of kidney disease in patients with hypertension and type 2 diabetes mellitus accompanied by hypertension

  • Hypertension
View approved original text

This medication is primarily used to treat hypertension. It is also used as a treatment regimen for kidney disease that may occur in patients with hypertension as well as type 2 diabetes. Therefore, it helps improve cardiovascular and kidney health associated with hypertension.

How to take

Adult dose

This drug may be taken without regard to meals, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses per day or, if necessary, increased to a maximum of 100 mg once daily. 3) If blood pressure is not controlled with this drug alone, it may be coadministered with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose of this drug is 50 mg once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be coadministered with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For patients older than 75 years, an initial dose of 25 mg of this drug once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this drug once daily is recommended. 3) Patients with reduced effective intravascular volume An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years or older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this drug once daily and may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily and may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children younger than 6 years: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication should not be used by pregnant women or women who may become pregnant, as it can cause serious harm especially to the fetus. Patients who have had allergic reactions to this drug, severe liver impairment, or a history of hereditary angioedema should avoid taking it. Particular caution is required when this medication is administered to elderly patients, those with impaired kidney function, or patients at risk of hyperkalemia. Since this medication lowers blood pressure, it may cause low blood pressure symptoms or kidney failure, so regular monitoring of blood pressure and kidney function is necessary. Care should be taken not to take potassium supplements or medications containing potassium simultaneously, as this medication may increase potassium levels. Dizziness or drowsiness may occur while taking this medication, so caution is needed when driving or operating machinery. Occasionally, side effects such as cough, headache, muscle pain, digestive discomfort may occur, and if a severe allergic reaction occurs, immediate consultation with medical personnel is advised. If pregnancy is confirmed, discontinue the medication immediately and consult a physician. It is also advisable to avoid taking it while breastfeeding. This medication may interact with other antihypertensives or certain medications, so it is important to inform your physician of all medications being taken. Overdose may cause low blood pressure and heart-related symptoms, so prescribed dosages and routes should be strictly followed. Keep this medication out of reach of children and ensure it is not transferred to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle spasm
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 125 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distention
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm scaling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • muscle weakness
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmare
  • sensory impairment
  • decreased libido
  • memory impairment
  • migraine
  • hyperesthesia
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver function abnormalities
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • asthenia
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopy
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1-30 degrees Celsius at room temperature. Storing it this way will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.